Sino-Foreign Interventional Medicine Synergy: Overseas Experts Explore Minimally Invasive Care at Danhui Medical

Recently, an overseas expert team visited Danhui Medical for an in-depth tour and exchange. Centered on product discussion, clinical application and cooperation pathways, this visit aimed to build a cooperation bridge for the Chinese and foreign minimally invasive medical fields, facilitate the precise matching of high-quality medical device technologies with overseas clinical needs, and lay a solid foundation for subsequent global strategic cooperation.

01  Technology as the Bridge, for a Win-Win Future

At the this visit, Ms. Yang, Chairman of Danhui Medical, delivered an address to extend a sincere welcome to the experts and convey the original aspiration for cooperation. She emphasized: "Currently, minimally invasive interventional therapy has become a core development direction in the global medical field. The clinical demand for such therapy in oncology, peripheral vascular diseases and other areas is rising steadily, which is highly aligned with the technological layout of Danhui Co-creation." Ms. Yang stated that Danhui Co-creation has always been guided by clinical needs to build a full-chain product system. Taking this visit as an opportunity, the company is willing to share technological achievements and co-develop tailored solutions with overseas experts, accurately match overseas medical scenarios through joint R&D, and build a long-term and stable global cooperation ecosystem.

02  Deep Alignment: Perfect Match of Product Indications

The Director of the Overseas Business Department at Danhui Medical presented the enterprise’s comprehensive strength to the overseas experts in a systematic manner from three core dimensions: full industrial chain layout, core technological barriers, and clinical application scenarios, and delivered an in-depth professional interpretation focusing on the indication scope and clinical adaptability of the flagship products. For many years of technological accumulation, Danhui Co-creation has built a flagship product portfolio centered on microwave ablation systems and varicose vein ablation catheters. All products have passed rigorous clinical validation and quality system certification, with core strengths lying in the precise coverage of clinically prevalent diseases by indications, the adaptability of operational procedures to diverse medical scenarios, and compliance of safety performance with international standards.

Prior to this visit, overseas experts had already applied Danhui’s flagship products in routine clinical diagnosis and treatment. The ease of practical operation, precision of curative effects and post-operative safety have won unanimous praise from the medical teams and high recognition from patients – which stands as the core driving force behind the expert team’s special trip across the globe to seek deeper cooperation and joint R&D.

03 Factory Visit & Ablation Demo: Experience Our Quality and Strength

In the Class 10,000 clean production workshop, the overseas expert team toured the core processes of microwave ablation systems in sequence, including precision machining and finished product quality inspection, and gained a detailed understanding of the raw material screening criteria, production process parameters and full-process quality control system.

At the technical demonstration area, the R&D department first conducted a complete demonstration of the entire workflow of the microwave ablation system—puncture positioning, power regulation and precise ablation—using a simulated tissue model as the carrier. A real-time temperature monitoring screen clearly displayed the core performance of "precision temperature control". After the observation, the overseas experts took the initiative to hands-on experience the grip and operational flexibility of microwave ablation needles, and held in-depth discussions with the technical team on clinical practical issues such as the puncture angle for thyroid nodule ablation and the power setting for liver tumor ablation. The intuitive demonstration and in-depth participation have further consolidated the technical consensus between the two parties.

04 Visit Danhui Medical & Chuangyu Ketai: Unlock Technological Innovation

In the afternoon, the experts visited Danhui Medical-Chuangyu Ketai for cross-enterprise technical exchanges. As an innovative enterprise focusing on the R&D of minimally invasive medical devices, Chuangyu Ketai’s R&D labs and production workshops were toured by the overseas experts, who gained a detailed understanding of its product iteration, technological R&D direction and clinical translation process. The experts fully experienced the innovative strength of the Danhui system’s integrated "industry-university-research-application" model, from large-scale mass production on the production line to other core capabilities. They spoke highly of the enterprise’s ability to continuously optimize product indications and iterate technical solutions, and clearly proposed a demand for joint development – hoping to leverage Danhui’s technological R&D strength and their own clinical practice experience to jointly explore more clinically applicable scenarios adapted to the overseas market and create customized minimally invasive diagnosis and treatment products that better meet local needs.

05 Invited Experts' Sharing: Deciphering Surgical Innovation

At the end of the visit, Invited Expert Dr. Zhang delivered a special academic presentation on Minimally Invasive Surgical Techniques for Thyroid and Varicose Vein Diseases. Through a professional presentation, Dr. Zhang systematically explained the key points of indication selection, operational norms, complication prevention and control, and post-operative follow-up for microwave ablation technology in the treatment of benign thyroid nodules. He also elaborated on the innovative application protocols and clinical efficacy data of endovenous microwave thermal ablation for lower extremity varicose veins. The clinical scenarios he presented were highly aligned with the indications of Danhui Co-creation’s products.

06 Based on Synergetic Alignment, Ushering in a New Journey of Cooperation

Centered on professional exchange, precise alignment and pragmatic cooperation, this visit enabled overseas experts to fully verify Danhui Co-creation’s product strength, technological innovation capability and production control standards across all dimensions. They highly affirmed the strong alignment between the company’s product indications and their business areas, as well as the excellent adaptability of the products in practical application.

Deepen technology for targeted empowerment; cross borders for win-win cooperation. Danhui Co-creation’s products have gained recognition in the overseas market with superior quality, and this upgraded strategic cooperation with overseas experts fully demonstrates the maturity, clinical adaptability and quality reliability of its medical technologies – the embodiment of China’s intelligent manufacturing. Taking this visit as a milestone, we will continue to focus on clinical needs, advance core technological innovation and optimize the coverage of product indications. With professional and international products and services, we will connect global medical resources, drive deeper and broader Sino-foreign cooperation in minimally invasive medicine, and contribute Chinese strength to the development of the global minimally invasive medical industry.